350 Odcinki

  1. Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing

    Opublikowany: 27.06.2019
  2. Episode 68: A controversial desire drug, courtroom genealogy, & the quest for longer life

    Opublikowany: 20.06.2019
  3. Episode 67: Biohacking meets bureaucracy, and the latest twist in CRISPR world

    Opublikowany: 13.06.2019
  4. Episode 66: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party

    Opublikowany: 6.06.2019
  5. Episode 65: A special episode from the halls of the ASCO meeting

    Opublikowany: 4.06.2019
  6. Episode 64: Feuding professors, failing businesses, and journalism 101

    Opublikowany: 30.05.2019
  7. Episode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer

    Opublikowany: 23.05.2019
  8. Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials

    Opublikowany: 16.05.2019
  9. Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA

    Opublikowany: 9.05.2019
  10. Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms

    Opublikowany: 2.05.2019
  11. Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup

    Opublikowany: 25.04.2019
  12. Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print

    Opublikowany: 18.04.2019
  13. Episode 57: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst

    Opublikowany: 11.04.2019
  14. Episode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound

    Opublikowany: 4.04.2019
  15. Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges

    Opublikowany: 28.03.2019
  16. Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores

    Opublikowany: 21.03.2019
  17. Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen

    Opublikowany: 14.03.2019
  18. Episode 52: Every conceivable angle of Scott Gottlieb's FDA resignation

    Opublikowany: 7.03.2019
  19. Episode 51: CEOs at the Senate, merger mania, and sleuthing startups

    Opublikowany: 28.02.2019
  20. Episode 50: A big scoop on opioid marketing

    Opublikowany: 22.02.2019

15 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site